Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Postprandial lipemia after an oral fat challenge was studied in middle-aged men with visceral obesity. The two groups had similar plasma cholesterol levels, but obese subjects had higher levels of plasma triglyceride and reduced amounts of high-density cholesterol. Fasting plasma insulin was fourfold greater in obese subjects because of concomitant insulin resistance, with a calculated HOMA score of 3.1 ± 0.6 vs. 0.8 ± 0.2, respectively. Plasma apolipoprotein B 48(apoB 48) and retinyl palmitate (RP) after an oral fat challenge were used to monitor chylomicron metabolism. Compared with lean subjects, the fasting concentration of apoB 48 was more than twofold greater in obese individuals, suggestive of an accumulation of posthydrolyzed particles. After the oral lipid load, the incremental areas under the apoB 48 and RP curves (IAUC) were both significantly greater in obese subjects (apoB 48: 97 ± 17 vs. 44 ± 12 μg · ml−1· h; RP: 3,120 ± 511 vs. 1,308 ± 177 U · ml−1· h, respectively). A delay in the conversion of chylomicrons to remnants probably contributed to postprandial dyslipidemia in viscerally obese subjects. The triglyceride IAUC was 68% greater in obese subjects (4.7 ± 0.6 vs. 2.8 ± 0.8 mM · h, P< 0.06). Moreover, peak postprandial triglyceride was delayed by ∼2 h in obese subjects. The reduction in triglyceride lipolysis in vivo did not appear to reflect changes in hydrolytic enzyme activities. Postheparin plasma lipase rates were found to be similar for lean and obese subjects. In this study, low-density lipoprotein (LDL) receptor expression on monunuclear cells was used as a surrogate marker of hepatic activity. We found that, in obese subjects, the binding of LDL was reduced by one-half compared with lean controls (70.9 ± 15.07 vs. 38.9 ± 4.6 ng LDL bound/μg cell protein, P = 0.02). Because the LDL receptor is involved in the removal of proatherogenic chylomicron remnants, we suggest that the hepatic clearance of these particles might be compromised in insulin-resistant obese subjects. Premature and accelerated atherogenesis in viscerally obese, insulin-resistant subjects may in part reflect delayed clearance of postprandial lipoprotein remnants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
Postprandial triglyceride response in visceral obesity in men
Couillard, C., Bergeron, N., Prud'homme, D., Bergeron, J., Tremblay, A., Bouchard, C., Mauriège, P., & Després, J. P. (1998) · Diabetes · doi:10.2337/diabetes.47.6.953 · Cited by 271
Research works printed but not linked: 33
- 10.1016/0002-9149(91)90856-G · DOI
- 10.1042/bj2760381 · DOI · Paper page
- 10.1002/(SICI)1096-9136(199711)14:11<942::AID-DIA500>3.0.CO;2-B · doi:10.1002/(sici)1096-9136(199711)14:11<942::aid-dia500>3.0.co;2-b
- Chen M, 1994, J Lipid Res, 35, 1918, 10.1016/S0022-2275(20)39938-7 · DOI · Paper page
- Cohn JS., 1998, Can J Cardiol, 14, 18B
- 10.1002/(SICI)1096-9136(199609)13:9<816::AID-DIA183>3.0.CO;2-L · DOI
- Després JP, 1990, Atherosclerosis, 10, 497
- 10.2337/diab.42.10.1474 · DOI
- 10.1097/00041433-199510000-00011 · DOI · Paper page
- 10.1016/0021-9150(94)90085-X · DOI · Paper page
- 10.1016/0026-0495(90)90249-C · DOI
- 10.1210/jcem-71-4-1041 · DOI · Paper page
- 10.1016/0005-2760(92)90298-A · doi:10.1016/0005-2760(92)90298-a
- 10.1046/j.1365-2362.1998.00284.x · DOI · Paper page
- 10.1007/BF00398049 · DOI
- 10.2337/diab.33.4.333 · DOI · Paper page
- McConathy WJ, 1992, J Lipid Res, 33, 995, 10.1016/S0022-2275(20)41415-4 · DOI · Paper page
- Mekki N, 1999, J Clin Endocrinol Metab, 84, 184
- 10.1038/sj.ijo.0801372 · DOI
- Nakao Y, 1993, Nippon Naibumpi Gakkai Zasshi-Folia Endocrinol Jpn, 69, 670
- 10.1152/ajpendo.1995.268.4.E588 · DOI · Paper page
- Pouiliot MC, 1990, J Lipid Res, 31, 1023, 10.1016/S0022-2275(20)42742-7 · DOI · Paper page
- 10.1172/JCI117213 · DOI · Paper page
- 10.2337/diab.36.3.327 · DOI
- 10.1038/sj.ijo.0800602 · DOI
- 10.1016/0021-9150(93)90267-X · DOI
- 10.1038/sj.ijo.0800604 · DOI
- 10.1177/000456329703400210 · DOI · Paper page
- 10.2337/diab.30.2.S1 · DOI · Paper page
- 10.1111/j.1432-1033.1988.tb14084.x · DOI · Paper page
- Windler E, 1985, J Lipid Res, 26, 556, 10.1016/S0022-2275(20)34342-X · DOI · Paper page
- Wu JH, 2000, J Formos Med Assoc, 99, 367
- 10.1016/0026-0495(91)90204-A · doi:10.1016/0026-0495(91)90204-a
Cited by
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
“Finally, the LDL receptor expression is reduced in obesity [66].”
BackgroundObesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association
Bays, H. E., Toth, P. P., Kris-Etherton, P. M., Abate, N., Aronne, L. J., Brown, W. V., Gonzalez-Campoy, J. M., Jones, S. R., Kumar, R., La Forge, R., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.04.001 · Cited by 521
Russell, J. C., & Proctor, S. D. (2006) · Cardiovascular Pathology · doi:10.1016/j.carpath.2006.09.001 · Cited by 317
The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state
Hodson, L., & Gunn, P. J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0256-9 · Cited by 309
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Ooi, E. M. M., Barrett, P. H. R., Chan, D. C., & Watts, G. F. (2008) · Clinical Science · doi:10.1042/cs20070308 · Cited by 282
Self-citation
Metadata
- Authors
- Mamo, J. C. L., Watts, G. F., Barrett, P. H. R., Smith, D., James, A. P., & Pal, S.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2001-09-01
- Volume
- 281
- Issue
- 3
- Pages
- E626-E632
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W1961362138
- Cited by
- 112
- References
- 4
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? https://app.cochat.ai/papers/10.1152/ajpendo.2001.281.3.e626
- The paper
- Mamo, J. C. L., Watts, G. F., Barrett, P. H. R., Smith, D., James, A. P., & Pal, S. (2001). Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.2001.281.3.e626
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.